Pirtobrutinib

In this video, Michael Choi, MD, discusses updated data on the results of pirtobrutinib treatments on mantle lymphocytic leukemia, presented at ASCO Annual Meeting.

In this video, Matthew Matasar, MD, chief of the division of blood disorders at Rutgers Cancer Institute, discusses mantle cell lymphoma research presented at ASCO Annual Meeting.

Justin Taylor, MD, spoke with Healio about a study he and colleagues conducted to examine mechanisms of resistance to noncovalent Bruton tyrosine kinase inhibitors.

Healio spoke with Shazia K. Nakhoda, MD, about CLL highlights from recent conferences.

Healio spoke with Shazia K. Nakhoda, MD, about incorporating new therapies into practice.

Healio spoke with Shazia K. Nakhoda, MD, about recent approvals and advancements in the management of CLL.

Healio spoke with Ryan. W. Jacobs, MD, about new treatments in the pipeline for CLL.

In this video, Brian Hill, MD, PhD, Director of the Lymphoid Malignancies Program and Staff Physician at the Cleveland Clinic Taussig Cancer Institute, discusses emerging therapies and drugs for mantle cell lymphoma treatment, and the potential utility of non-covalent BTK inhibitors.

In this video, Brad Kahl, MD, a professor in the oncology division of the Washington University School of Medicine in St. Louis, discusses emerging therapies for mantle cell lymphoma, including new BTK inhibitors and a bispecific monoclonal antibody.